Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial-Reference-Cited by-同舟云学术

Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial

Published:2016-04-04 Issue:1 Volume:15 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Tanaka Atsushi,Inoue Teruo,Kitakaze Masafumi,Oyama Jun-ichi,Sata Masataka,Taguchi Isao,Shimizu Wataru,Watada Hirotaka,Tomiyama Hirofumi,Ako Junya,Sakata Yasushi,Anzai Toshihisa,Uematsu Masaaki,Suzuki Makoto,Eguchi Kazuo,Yamashina Akira,Saito Yoshihiko,Sato Yasunori,Ueda Shinichiro,Murohara Toyoaki,Node Koichi

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-016-0381-x

Reference57 articles.

1. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009;73:1893–900.

2. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan–first report from the CHART-2 study. Circ J. 2011;75:823–33.

3. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006;119:591–9.